324 related articles for article (PubMed ID: 35632430)
1. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.
Loconsole D; Centrone F; Sallustio A; Accogli M; Casulli D; Sacco D; Zagaria R; Morcavallo C; Chironna M
Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632430
[TBL] [Abstract][Full Text] [Related]
2. Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.
Moustsen-Helms IR; Bager P; Larsen TG; Møller FT; Vestergaard LS; Rasmussen M; Hansen CH;
Lancet Infect Dis; 2024 May; ():. PubMed ID: 38761806
[TBL] [Abstract][Full Text] [Related]
3. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
[TBL] [Abstract][Full Text] [Related]
4. Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.
Parums DV
Med Sci Monit; 2023 Feb; 29():e939580. PubMed ID: 36722047
[TBL] [Abstract][Full Text] [Related]
5. Autochthonous Outbreak of SARS-CoV-2 Omicron Variant in Booster-Vaccinated (3 Doses) Healthcare Workers in Southern Italy: Just the Tip of the Iceberg?
Loconsole D; Bisceglia L; Centrone F; Sallustio A; Accogli M; Dalfino L; Brienza N; Chironna M
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214741
[TBL] [Abstract][Full Text] [Related]
6. The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children.
Setiabudi D; Sribudiani Y; Hermawan K; Andriyoko B; Nataprawira HM
Front Pediatr; 2022; 10():898463. PubMed ID: 35983081
[TBL] [Abstract][Full Text] [Related]
7. Omicron new variant BA.2.86 (Pirola): Epidemiological, biological, and clinical characteristics - a global data-based analysis.
Meo SA; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9470-9476. PubMed ID: 37843359
[TBL] [Abstract][Full Text] [Related]
8. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
[TBL] [Abstract][Full Text] [Related]
9. The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review.
Sarkar A; Omar S; Alshareef A; Fanous K; Sarker S; Alroobi H; Zamir F; Yousef M; Zakaria D
Hum Vaccin Immunother; 2023 Dec; 19(1):2212568. PubMed ID: 37254497
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and high-resolution computed tomography findings of 805 patients with mild or moderate infection from SARS-CoV-2 Omicron subvariant BA.2.
Pan YN; Gu MY; Mao QL; Ruan XZ; Du XF; Gao X; Chen XQ; Li AJ
Curr Med Imaging; 2023 Apr; ():. PubMed ID: 37170975
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients.
Deng H; Mai Y; Liu H; Guan J
Ann Hepatol; 2023; 28(1):100763. PubMed ID: 36182032
[TBL] [Abstract][Full Text] [Related]
12. The First Identification in Italy of SARS-CoV-2 Omicron BA.4 Harboring KSF141_del: A Genomic Comparison with Omicron Sub-Variants.
Peronace C; Tallerico R; Colosimo M; Fazio M; Pasceri F; Talotta I; Panduri G; Pintomalli L; Oteri R; Calantoni V; Fiorillo MT; Caroleo MC; Curcio R; Dolce V; Cione E; Minchella P
Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009386
[TBL] [Abstract][Full Text] [Related]
13. As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
Xu R; Wang W; Zhang W
Front Public Health; 2022; 10():1039123. PubMed ID: 36504951
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California.
Lewnard JA; Hong VX; Patel MM; Kahn R; Lipsitch M; Tartof SY
Nat Med; 2022 Sep; 28(9):1933-1943. PubMed ID: 35675841
[TBL] [Abstract][Full Text] [Related]
15. Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak.
Cheng VCC; Ip JD; Chu AWH; Tam AR; Chan WM; Abdullah SMU; Chan BPC; Wong SC; Kwan MYW; Chua GT; Ip P; Chan JMC; Lam BHS; To WK; Chuang VWM; Yuen KY; Hung IFN; To KKW
Clin Infect Dis; 2022 Aug; 75(1):e44-e49. PubMed ID: 35271728
[TBL] [Abstract][Full Text] [Related]
16. Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5.
Krenn F; Dächert C; Badell I; Lupoli G; Öztan GN; Feng T; Schneider N; Huber M; Both H; Späth PM; Muenchhoff M; Graf A; Krebs S; Blum H; Durner J; Czibere L; Kaderali L; Keppler OT; Baldauf HM; Osterman A
Med Microbiol Immunol; 2023 Oct; 212(5):323-337. PubMed ID: 37561225
[TBL] [Abstract][Full Text] [Related]
17. An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China.
Zhang M; Chen Z; Zhou J; Zhao X; Chen Y; Sun Y; Liu Z; Gu W; Luo C; Fu X; Zhao X
Biosaf Health; 2022 Dec; 4(6):406-409. PubMed ID: 36320663
[TBL] [Abstract][Full Text] [Related]
18. Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2.
Parums DV
Med Sci Monit; 2022 Jul; 28():e937676. PubMed ID: 35775166
[TBL] [Abstract][Full Text] [Related]
19. The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution.
Veneziano C; Marascio N; De Marco C; Quaresima B; Biamonte F; Trecarichi EM; Santamaria G; Quirino A; Torella D; Quattrone A; Matera G; Torti C; De Filippo C; Costanzo FS; Viglietto G
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851622
[TBL] [Abstract][Full Text] [Related]
20. High-resolution melting analysis to discriminate between the SARS-CoV-2 Omicron variants BA.1 and BA.2.
Koshikawa T; Miyoshi H
Biochem Biophys Rep; 2022 Sep; 31():101306. PubMed ID: 35791375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
